Arnogene: A Phosphocalcic Study in Dialysis (ARNOGENE)

September 3, 2009 updated by: Hospices Civils de Lyon

Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients

Searching for high morbi-mortality risk Klotho variants in dialysis patients

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Lyon, France
        • Hôpital Edouard Herriot

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients undergoing maintenance dialysis since at leat three months

Description

Inclusion Criteria:

  • Every adult > 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
hemodialysis patients
Adult patients undergoing maintenance dialysis since at leat three months
Genetic: blood sample
Searching for Klotho variants in DNA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Assessing morbi-mortality based on Klotho variants

Secondary Outcome Measures

Outcome Measure
Survival and serum phosphocalcic parameters

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Investigators

  • Principal Investigator: FOUQUE Denis, MD, Hospices Civils de Lyon
  • Principal Investigator: LEGRAND Eric, MD, Ch Annonay
  • Principal Investigator: KAARASLAN Huseyin, MD, CH Bourgoin Jallieu
  • Principal Investigator: ABOKASEM Ayman, MD, CH Chalon/saône
  • Principal Investigator: LATAILLADE Claire Dominique, MD, CH Sallanches
  • Principal Investigator: KUENTZ François, MD, Centre Dialyse eaux claires
  • Principal Investigator: HACHACHE Toufic, MD, CHU Grenoble - La tronche
  • Principal Investigator: LEITIENNE Philippe, MD, Hospices Civils de Lyon
  • Principal Investigator: ARKOUCHE Walid, MD, AURAL - Lyon
  • Principal Investigator: HEYANI Ahmed, MD, CH Mâcon
  • Principal Investigator: HANNOUN Jacques, MD, CH Villefranche/saône
  • Principal Investigator: COMBARNOUS François, MD, Clinique du Tonkin VILLEURBANNE
  • Principal Investigator: MAUREAUGANDRY Xavier, MD, AGDUC - Montélimar
  • Principal Investigator: SIRAJEDINE Mohamed, MD, CH ROMANS/ISERE
  • Principal Investigator: JEAN Ahmed, MD, Centre du Rein - Tassin la demi lune
  • Principal Investigator: DENICOLA Cora, MD, Calydial - CH Viennes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2008

Study Completion (Actual)

February 1, 2009

Study Registration Dates

First Submitted

March 6, 2009

First Submitted That Met QC Criteria

March 6, 2009

First Posted (Estimate)

March 9, 2009

Study Record Updates

Last Update Posted (Estimate)

September 4, 2009

Last Update Submitted That Met QC Criteria

September 3, 2009

Last Verified

September 1, 2009

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2007.471/14

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dialysis

Clinical Trials on blood sample

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe